Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout
Clinical trial NCT00325195 · COMPLETED
Trial details
- NCT number
- NCT00325195
- Sponsor
- Savient Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2007-10-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.